The Mount Sinai Hospital Recognized on Newsweek’s “America’s Best Maternity Hospitals 2022” List

The Mount Sinai Hospital has earned top honors on Newsweek’s list of “America’s Best Maternity Hospitals 2022” for providing high-quality maternity care from pregnancy through birth, as well as postpartum care to ensure the long-term health of both newborns and new mothers.

Mount Sinai Receives Landmark Gift from Royalty Pharma to Advance Health Equity

Marking a major advance in its efforts to achieve equity in the delivery of health care, the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) announced today that its Institute for Health Equity Research (IHER) has received a landmark $20 million gift over five years from Royalty Pharma plc (Nasdaq: RPRX) and certain members of its management team.

Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates

Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high risk for recurrence, according to clinical trial results presented at the American Urological Association (AUA) annual meeting in May.

Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai Announce a Joint Center for Engineering and Precision Medicine in New York City

Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai today announced the creation of the Center for Engineering and Precision Medicine (CEPM), one of the first centers in the nation to bridge engineering and engineering science with medicine. This undertaking will build on a wealth of shared basic research discoveries, explore unique therapeutic innovations in cancer, Alzheimer’s and a myriad of infectious diseases; educate a new generation of biomedical leaders; and develop new technologies and processes that enhance patient outcomes in unprecedented ways. CEPM represents an evolution in the successful partnership between Mount Sinai and RPI, one that has secured over $70 million in shared research funding since 2013 with 90 percent of that provided by the National Institutes of Health.

Neighborhoods Most Affected by Racism, Inequities and COVID-19 Pandemic Stressors at a Greater Risk for Preterm Births, Study Finds

The cohort study follows women through pregnancy and birth to study if a SARS-CoV-2 infection, the virus that causes COVID-19, is associated with poor pregnancy outcomes.

Mount Sinai’s Brendan Carr, MD, MS, Receives Prestigious “Chair of the Year Award” from Emergency Medicine Residents’ Association

The Emergency Medicine Residents’ Association (EMRA) of the American College of Emergency Physicians has honored Brendan G. Carr, MD, MS, Chair of Emergency Medicine at the Icahn School of Medicine of Mount Sinai and Mount Sinai Health System, with the prestigious “2022 Chair of the Year Award.” He is the only department chair in the country to receive this distinction for 2022, recognizing his exceptional leadership.

Mount Sinai Cardiologist Develops New Risk Score to Help Predict Possible Contrast-Associated Kidney Injury After Percutaneous Coronary Intervention

Assessment can help stratify high-risk patients for monitoring before, during, and after procedures to improve outcomes

Novel Surgical Device Can Potentially Improve Outcomes of Coronary Bypass Grafting That Uses Leg Veins

(New York, NY – November 13, 2021) –A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial done in collaboration…

New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes

Study outlines better way to identify where stents are necessary

Renowned Physician-Scientist with Expertise in High-Risk Pregnancies Named System Chair of Obstetrics, Gynecology, and Reproductive Science at Mount Sinai Health System

Joanne L. Stone, MD, a leading physician-scientist in women’s health with special expertise in fetal imaging and caring for high-risk pregnancies, has been named the Chair of Obstetrics, Gynecology, and Reproductive Science for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System. Dr. Stone currently serves as Director of the Maternal-Fetal Medicine and Fellowship program for the Mount Sinai Health System, Vice Chair for Diversity and Inclusion of the OB/GYN Department, and Immediate Past President of the Faculty Council.

32BJ Health Fund, In Partnership With Mount Sinai Health System, Announces First-In-The-Nation Regional Centers of Excellence

The 32BJ Health Fund and the Mount Sinai Health System today announced expansion of their unique Centers of Excellence program, which provides bariatric and joint replacement surgeries at no-cost to Fund participants, to include partner hospitals in New Jersey, Connecticut, Florida, Massachusetts, and Pennsylvania.

Shrinking Waveforms on Electrocardiograms Predict Worsening Health and Death of Hospitalized COVID-19 and Influenza Patients

Spotting changes in the heart’s electrical activity may prompt more-aggressive treatment and monitoring.

Mount Sinai Neurobiologist Selected as a Howard Hughes Medical Institute Investigator

The Howard Hughes Medical Institute (HHMI) has selected Ian Maze, PhD, Associate Professor of Neuroscience, and Pharmacological Sciences, at the Icahn School of Medicine at Mount Sinai, as an HHMI Investigator.

Mount Sinai Researchers Use Wearable Devices to Identify Psychological Effects of Pandemic

Study links changes in heart rate variability with degree of resilience, as part of larger effort to understand and mitigate the effects of COVID-19 on health care workers

Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Receives $5 Million Grant From The Bob & Renee Parsons Foundation

Funds will support cutting-edge MDMA-assisted therapy for PTSD

Mount Sinai Health System Generates More Than $28 Million in Medicare Savings by New York Medical Partners ACO

New York Medical Partners ACO, LLC (NYMP), met quality and cost goals for the management of about 50,000 Medicare beneficiaries in the Medicare Shared Savings Program, resulting in more than $28 million in savings to Medicare, according to recently released performance data from the Centers for Medicare & Medicaid Services (CMS).

Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial

Mount Sinai Receives $2.9 Million to Study First-of-its-kind Brain Implant for Restoring Function in Paralyzed Patients

Department of Rehabilitation and Human Performance will lead Mount Sinai in national clinical trial

Mount Sinai Queens Earns Prestigious Thrombectomy-Capable Stroke Certification From Joint Commission

The hospital achieved this recognition by meeting rigorous standards for performing endovascular thrombectomy and demonstrating continuous compliance with its performance standards.

New Study Provides Structural Insights into How Cholesterol in the Brain Regulates Ion Channels and Alters Their Function; Findings Could Facilitate the Development of Therapeutics for Neurological Diseases

UNDER EMBARGO UNTIL 11am EST on August 24: Cell Reports   Senior Author: Paul A. Slesinger, PhD, Lillian and Henry M. Stratton Professor of Neuroscience and Director of the Center for Neurotechnology and Behavior, Icahn School of Medicine at Mount Sinai,…

Mount Sinai Study Identifies Significant Inequalities Among Low-Risk Births, Finds Higher Rates of Unexpected Complications for Black and Hispanic Infants

Hospital quality of care during delivery is a major factor for racial and ethnic disparities among low-risk newborns

First of its kind study using multi-omics approach identifies large list of candidate genes associated with alcohol use disorder

New York, NY (Aug 20, 2021) – Researchers from the Icahn School of Medicine at Mount Sinai have published the first study of its kind in the field of addiction genetics using a multi-omics approach to provide a large list…

Mount Sinai Receives NCI Grant to Study Anal Cancer Screening in High-Risk Women

The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection.

Study shows neutralizing antibodies to SARS-CoV-2 remain relatively high for up to 13 months following infection

  New York, NY – Researchers from the Icahn School of Medicine at Mount Sinai have found that most COVID-19 patients have persistent antibodies to the SARS-CoV-2 virus at levels that are correlated with neutralization of the virus more than…

Mount Sinai Mobile Interventional Stroke Team Travels to Patients, Resulting in Faster Treatment and Better Outcomes

Study finds stroke patients are nearly twice as likely to be functionally independent if treated by a specialized team that travels to them to perform surgical clot removal

Study Shows Visual Evoked Potential Is a Promising Tool for Translational Research Into Phelan-McDermid Syndrome and Autism Spectrum Disorders

Researchers at the Seaver Autism Center for Research and Treatment at Mount Sinai have identified specific transient visual evoked potential waveform abnormalities in individuals with Phelan-McDermid syndrome (PMS), proving the method to be an effective, noninvasive technique to gather objective data from a range of individuals, including those who are profoundly affected.

Mount Sinai’s J Mocco, MD, to Lead the Society of NeuroInterventional Surgery

J Mocco, MD, MS, Senior Vice Chair, Director of the Cerebrovascular Center, and Co-Director of the Neuroendovascular Surgery Fellowship Program in the Department of Neurosurgery at Mount Sinai, has been named president-elect of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery, effective July 29, 2021.

The Mount Sinai Hospital’s Department of Geriatrics Remains No. 1 in U.S. News & World Report Specialty Rankings for Second Year

The Mount Sinai Hospital’s Department of Geriatrics was ranked No. 1 in the nation by U.S. News & World Report for the second consecutive year. The Mount Sinai Hospital was also listed on the “Honor Roll” of the nation’s top 20 hospitals for the sixth year in a row.

Mount Sinai scientists discover early signs of frontotemporal dementia in personalized cerebral organoids

Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures. In an article published July 26 in Cell, Mount Sinai researchers describe how they were able to recreate much of the damage seen in a widely studied form of the disease by growing special types of cerebral organoids in petri dishes.

The Steven & Alexandra Cohen Foundation Grants More than $2.1 Million to Support a Psychedelics Research Study at Mount Sinai

The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the Steven & Alexandra Cohen Foundation.

Mount Sinai Researchers Develop Novel Therapy That Could Be Effective in Many Cancers

Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.

Mount Sinai Research Reveals How the Ebola Virus Manages to Evade the Body’s Immune Defenses

Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published in mBio, the team reported how a protein of the Ebola virus, VP24, interacts with the double-layered membrane of the cell nucleus (known as the nuclear envelope), leading to significant damage to cells along with virus replication and the propagation of disease.

Mount Sinai Welcomes Robotic Prostate Surgery Pioneer Mani Menon, MD

Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.

Mount Sinai Leaders Discuss Equity, the Impact of the Pandemic on Healthcare, and the Unprecedented Era and Increasing Interest of Psychedelics on Treating Mental Health at the 2021 Aspen Ideas Health and Aspen Ideas Festival

Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.